• español
  • English
  • français
  • Deutsch
  • português (Brasil)
  • italiano
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Parcourir

    Tout UVaDOCCommunautésPar date de publicationAuteursSujetsTitres

    Mon compte

    Ouvrir une session

    Statistiques

    Statistiques d'usage de visualisation

    Compartir

    Voir le document 
    •   Accueil de UVaDOC
    • PUBLICATIONS SCIENTIFIQUES
    • Departamentos
    • Dpto. Bioquímica y Biología Molecular y Fisiología
    • DEP06 - Artículos de revista
    • Voir le document
    •   Accueil de UVaDOC
    • PUBLICATIONS SCIENTIFIQUES
    • Departamentos
    • Dpto. Bioquímica y Biología Molecular y Fisiología
    • DEP06 - Artículos de revista
    • Voir le document
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano

    Exportar

    RISMendeleyRefworksZotero
    • edm
    • marc
    • xoai
    • qdc
    • ore
    • ese
    • dim
    • uketd_dc
    • oai_dc
    • etdms
    • rdf
    • mods
    • mets
    • didl
    • premis

    Citas

    Por favor, use este identificador para citar o enlazar este ítem:https://uvadoc.uva.es/handle/10324/73938

    Título
    Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation
    Autor
    González Valdivieso, JuanAutoridad UVA Orcid
    Girotti ., AlessandraAutoridad UVA Orcid
    Schneider, Jose
    Arias Vallejo, Francisco JavierAutoridad UVA Orcid
    Año del Documento
    2021
    Editorial
    Elsevier
    Descripción
    Producción Científica
    Documento Fuente
    International Journal of Pharmaceutics, April 2021, vol. 599, 120438
    Résumé
    Cancer has reached pandemic dimensions in the whole world. Although current medicine offers multiple treatment options against cancer, novel therapeutic strategies are needed due to the low specificity of chemotherapeutic drugs, undesired side effects and the presence of different incurable types of cancer. Among these new strategies, nanomedicine arises as an encouraging approach towards personalized medicine with high potential for present and future cancer patients. Therefore, nanomedicine aims to develop novel tools with wide potential in cancer treatment, imaging or even theranostic purposes. Even though numerous preclinical studies have been published with successful preliminary results, promising nanosystems have to face multiple obstacles before adoption in clinical practice as safe options for patients with cancer. In this MiniReview, we provide a short overview on the latest advances in current nanomedicine approaches, challenges and promising strategies towards more accurate cancer treatment.
    Palabras Clave
    Cancer
    Nanomedicine
    Chemotherapy
    Drug delivery
    Nanodrugs
    ISSN
    0378-5173
    Revisión por pares
    SI
    DOI
    10.1016/j.ijpharm.2021.120438
    Patrocinador
    Ministerio de Ciencia, Innovación y Universidades (PID2019-106386RB-I00)
    CIBER-BBN (DTS19/00162)
    Version del Editor
    https://www.sciencedirect.com/science/article/pii/S0378517321002428
    Propietario de los Derechos
    © 2021 Elsevier
    Idioma
    eng
    URI
    https://uvadoc.uva.es/handle/10324/73938
    Tipo de versión
    info:eu-repo/semantics/submittedVersion
    Derechos
    openAccess
    Aparece en las colecciones
    • DEP06 - Artículos de revista [352]
    Afficher la notice complète
    Fichier(s) constituant ce document
    Nombre:
    advanced-nanomedicine-cancer-challenges-opportunities_preprint.pdf
    Tamaño:
    434.2Ko
    Formato:
    Adobe PDF
    Thumbnail
    Voir/Ouvrir
    Attribution-NonCommercial-NoDerivatives 4.0 InternacionalExcepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 Internacional

    Universidad de Valladolid

    Powered by MIT's. DSpace software, Version 5.10